Michael Anstey
InvestorPartner at Cambridge Innovation Capital
Cambridge, United Kingdom
Writes $600K – $6M checks · typically $3.3M
About
Michael Anstey pairs a DPhil in Zoology with co-founding an early-stage biotech targeting protein–protein interactions, backed Bicycle Therapeutics and Nuclera, and co-founded Innovate Cambridge to boost Greater Cambridge's innovation ecosystem.
Contact· self-published, not guessed
Invests in
AI & Machine LearningBiotechDeep TechHardwareHealthtechSemiconductors
Experience
- Cambridge Innovation CapitalPartnercurrent2017 — presentCambridge, United Kingdom
- TRIMTECH Therapeutics LimitedBoard Membercurrent2024 — presentCambridge
- NucleraBoard Observercurrent2024 — presentCambridge, England, United Kingdom
- ImmutrinBoard Membercurrent2022 — presentCambridge, England, United Kingdom
- EpitopeaBoard Membercurrent2021 — presentCambridge, England, United Kingdom
- Innovate CambridgeBoard Membercurrent2022 — presentCambridge, England, United Kingdom
- Start CodonBoard Membercurrent2019 — presentCambridge, United Kingdom
- CongenicaBoard Member2018 — 2025Cambridge, United Kingdom
- STORM Therapeutics LimitedBoard Member2018 — 2023Cambridge, United Kingdom
- Bicycle TherapeuticsBoard Member2017 — 2020Cambridge, United Kingdom
- Proteorex Therapeutics Inc.Co-Founder2014 — 2018Toronto, Canada Area
- The Boston Consulting GroupPrincipal2010 — 2017Toronto, Canada
- Oxford Capital PartnersInvestment Analyst2008 — 2009Oxford, United Kingdom
Skills & more
Leadership23Strategy10Team Leadership2Valuation3Venture Capital29Corporate Development4Due Diligence6Business Strategy30Investments9Healthcare2Research7Management Consulting15
+7 more
Change ManagementScienceStart-upsLifesciencesPrivate EquityFinancial ModelingProject Team ManagementFrom Michael's professional profile.
Colleagues at Cambridge Innovation Capital
Adam Glinsman
Investor at Cambridge Innovation Capital
Andrew Williamson
Managing Partner at Cambridge Innovation Capital
Andy Neely
Vice Chair at Cambridge Innovation Capital
Andy Richards
Investor at Cambridge Innovation Capital
Anne Horgan
Partner at Cambridge Innovation Capital
Christopher Tapper
Senior Associate at Cambridge Innovation Capital
Damian Crowther
Entrepreneur in Residence at Cambridge Innovation Capital
Dipesh Patel
Operating Partner at Cambridge Innovation Capital
Network4
Andrew Williamson
Managing Partner at Cambridge Innovation Capital
Anne Horgan
Partner at Cambridge Innovation Capital
Christopher Tapper
Senior Associate at Cambridge Innovation Capital
Edward Inns
Principal at Cambridge Innovation Capital
Investors connected to Michael in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Michael Anstey?
- Michael Anstey pairs a DPhil in Zoology with co-founding an early-stage biotech targeting protein–protein interactions, backed Bicycle Therapeutics and Nuclera, and co-founded Innovate Cambridge to boost Greater Cambridge's innovation ecosystem.
- Where does Michael Anstey work?
- Michael Anstey is Partner at Cambridge Innovation Capital.
- What does Michael Anstey invest in?
- Michael Anstey invests in AI & Machine Learning, Biotech, Deep Tech, Hardware, Healthtech, Semiconductors.
- What check size does Michael Anstey write?
- Michael Anstey typically writes checks of $600K – $6M.
- Where did Michael Anstey go to school?
- Michael Anstey studied at Kauffman Fellow (Class 22); University of Oxford (DPhil, Department of Zoology); Queen's University (First Class BSc(Hons), Biology).
Same school
Also attended University of Oxford990
Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageBrad GerstnerFounder & CEO of Altimeter CapitalGabriel PereyraCo-founder & President of HarveyDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index Ventures
+ 984 more
Also attended Queen's University226
Steph TryphonasCo-founder of Collaborative RoboticsHark AhluwaliaAssociate at RevolutionSydney SloanChief Marketing Officer at Scale Venture PartnersZeya YangInvestor at IVP (Institutional Venture Partners)Curtis UrbanowiczInvestment at Makers FundSanjiv KalevarPartner at Mucker Capital
+ 220 more
Shared employers
Also worked at TRIMTECH Therapeutics Limited3
Also worked at Nuclera1
Also worked at Immutrin3
Also worked at STORM Therapeutics Limited6
Robert TansleyPartner at Cambridge Innovation CapitalChristine MartinHead of Ventures at University of Cambridge EnterpriseHakan GokerManaging Director at M VenturesSeiji MiyaharaSenior Investment Director at Taiho Ventures, LLCTony KouzaridesVenture Partner / Resident Knight at Fifty YearsChristopher O'DonnellPartner at Pfizer Venture Investments
